These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

130 related items for PubMed ID: 4673447

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Tryptophan malabsorption in levodopa-treated parkinsonian patients. Effect of tryptophan on mental disturbances.
    Lehmann J.
    Acta Med Scand; 1973; 194(3):181-9. PubMed ID: 4746526
    [No Abstract] [Full Text] [Related]

  • 7. [Antagonism and competition between Parkinson's syndrome and the chorea and athetosis syndrome. Clinical cases of the association (including an anatomoclinical case). The abnormal movements provoked by levodopa in Parkinsonian patients].
    Sigwald J, Chomette G, Raymondeaud C.
    Sem Hop; 1972 Feb 20; 48(9):609-24. PubMed ID: 4339429
    [No Abstract] [Full Text] [Related]

  • 8. Long-term effects of levodopa in the severely disabled patient.
    Sacks OW, Messeloff CR, Schwartz WF.
    JAMA; 1970 Sep 28; 213(13):2270. PubMed ID: 5468938
    [No Abstract] [Full Text] [Related]

  • 9. Levodopa and amantadine in the treatment of Parkinsonism.
    Critchley E.
    Practitioner; 1972 Apr 28; 208(246):499-504. PubMed ID: 5031037
    [No Abstract] [Full Text] [Related]

  • 10. Levodopa and related drugs.
    Med Lett Drugs Ther; 1973 Mar 02; 15(5):21-3. PubMed ID: 4697470
    [No Abstract] [Full Text] [Related]

  • 11. Levodopa and parkinsonism: clinical impressions.
    Yahr MD.
    Clin Pharmacol Ther; 1971 Mar 02; 12(2):332-4. PubMed ID: 5577481
    [No Abstract] [Full Text] [Related]

  • 12. [Treatment of Parkinsonic syndrome with levo-Dopa. Case reports].
    Rosati G, Agnetti V, Mura F, Granieri E.
    Minerva Med; 1974 May 02; 65(33):1811-23. PubMed ID: 4602058
    [No Abstract] [Full Text] [Related]

  • 13. Deanol in the treatment of levodopa-induced dyskinesias.
    Miller E.
    Neurology; 1974 Feb 02; 24(2):116-9. PubMed ID: 4855678
    [No Abstract] [Full Text] [Related]

  • 14. "On-off" phenomenon with levodopa therapy in Parkinsonism. Clinical and pharmacologic correlations and the effect of intramuscular pyridoxine.
    Fahn S.
    Neurology; 1974 May 02; 24(5):431-41. PubMed ID: 4857104
    [No Abstract] [Full Text] [Related]

  • 15. Parkinsonism-dementia of Guam: treatment with L-dopa.
    Schnur JA, Chase TN, Brody JA.
    Neurology; 1971 Dec 02; 21(12):1236-42. PubMed ID: 4257247
    [No Abstract] [Full Text] [Related]

  • 16. Parkinsonism-dementia of Guam: treatment with levodopa and L-alpha-methyldopahydrazine.
    Holden EM, Brody JA, Chase TN.
    Neurology; 1974 Mar 02; 24(3):263-5. PubMed ID: 4855953
    [No Abstract] [Full Text] [Related]

  • 17. [Indications and results of monoamine treatment in parkinsonian syndromes].
    Boudin G, Pépin B, Guillard A, Fabiani JM, Haguenau M.
    Rev Neurol (Paris); 1972 Jul 02; 127(1):79-97. PubMed ID: 4520464
    [No Abstract] [Full Text] [Related]

  • 18. [Preliminary impressions of the therapeutic effectiveness of L-dopa in Parkinson's disease].
    Buscaino GA, Campanella G.
    Sist Nerv; 1970 Jul 02; 22(2):82-91. PubMed ID: 5504561
    [No Abstract] [Full Text] [Related]

  • 19. [Levodopa and Parkinsonism. A double-blind study].
    Pakkenberg H, Dupont E, Garde B, Hansen E, Melsen S, Vestberg F.
    Ugeskr Laeger; 1971 Nov 19; 133(46):2275-9. PubMed ID: 4944650
    [No Abstract] [Full Text] [Related]

  • 20. Long-lasting dyskinesia induced by levodopa.
    Weiss JL, Ng LK, Chase TN.
    Lancet; 1971 May 15; 1(7707):1016-7. PubMed ID: 4102427
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.